FTC sues significant pharmacy benefit supervisors above insulin costs The agency introduced motion from Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the listing price of life-saving insulin medications. Insurers will continue on vertically integrating to maintain extra revenue in-house, and federal scru... https://kylerrjzof.activablog.com/30078127/the-smart-trick-of-healthcare-news-that-nobody-is-discussing